342TiP Phase 3 trial of pembrolizumab as a first-line treatment in subjects with recurrent/metastatic head and neck squamous cell carcinoma: KEYNOTE-048

Autor:	C.J. Yen, A. Klochikhin, E. Cohen, J. Vermorken, K. Harrington, M. Tahara, J.Y. Ge, J. Geib, F. Jin, B. Burtness
Rok vydání:	2015
Předmět:	Oncology Hematology
Zdroj:	Annals of Oncology. 26:ix93
ISSN:	0923-7534
DOI:	10.1093/annonc/mdv527.29
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b6f4fd322b7a8d2a7ba8e45f1ab104f7 https://doi.org/10.1093/annonc/mdv527.29 Zobrazit plný text záznamu